Protective effect of N-acetyl cysteine and/or pro vitamin A against monosodium glutamate-induced cardiopathy in rats

Journal of Pharmacology and Toxicology

Volumn 4, Issue 5, 2009, Pages 178-193

  Abdel Baky, Nayira A ^a   Mohamed, Azza M ^b   Faddah, L M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

carotene; Heart; Lipids; Monosodium glutamate; N acetyl cysteine

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BETA CAROTENE; BIOLOGICAL MARKER; CATALASE; CREATINE KINASE; GLUCOSE; GLUTAMATE SODIUM; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART INJURY; HEART PROTECTION; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 75649107637     PISSN: 1816496X     EISSN: None     Source Type: Journal    
DOI: 10.3923/jpt.2009.178.193     Document Type: Article

References (106)

1. Adachi, Y., Y.Y. Oshikawa and H. Sakurai, 2007. Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: Evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities. Bio. Factors, 29: 213-223.
2. Aebi, H., 1984. Catalase in vitro. Methods Enzymol., 105: 121-126.
3. Ahluwalia, P., K. Tiwari and P. Choudhary, 1996. Studies on the effects on monosodium glutamate (MSG) on oxidative stress in erythrocytes of adult male mice. Toxicol. Lett., 84: 161-165.
4. Argolo, A.C., A.E. Sant'Ana, M. Pletsch and L.C. Coelho, 2004. Antioxidant activity of leaf extracts from Bauhinia monandra. Bioresour. Technol., 95: 229-233.
5. Bai, S.K., S.J. Lee, H.J. Na, K.S. Ha and J.A. Han et al., 2005. Beta-carotene inhibits inflammatory gene expression in lipopolysaccharidestimulated macrophages by suppressing redox-based NF-kappaB activation. Exp. Mol. Med., 37: 323-334.
6. Beck, J., L. Ferrucci, K. Sun, L.P. Fried, R. Varadhan, J. Walston, J.M. Guralnik and R.D. Semba, 2008. Circulating oxidized low-density lipoproteins are associated with overweight, obesity, and low serum carotenoids in older community-dwelling women. Nutration, 24: 964-968.
7. Bellisle, F., A.M. Dalix, A.S. Chappuis, F. Rossi and P. Fiquet, 1996. Monosodium glutamate affects mealtime food selection in diabetic patients. Appetite, 26: 267-276.
8. Bentler, E., O. Duran and K.B. Mikus, 1963. Improved method for determination of blood glutathione. J. Lab. Clin. Med., 61: 882-887.
9. Bergmeyer, H.V., M. Herder and R. Rej, 1986. Approved recommendation (1985) on IFCC methods for the measurement of catalytical concentration of enzymes, Patr 2. IFCC method for aspartate aminotransferase. J. Clin. Chem. Clin. Biochem., 24: 497-510.
10. Berner, Y.N. and F. Stern, 2004. Energy restriction controls aging through neuroendocrine signal transduction. Age. Res. Rev., 3: 189-198.
11. Beutner, S., B. Bloedorn, S. Frixel, I.H. Blanco and T. Hoffmann et al., 2001. Quantitative assessment of antioxidant properties of natural colorants and phytochemicals: Carotenoids, flavonoids, phenols and indigoids. The role of b-carotene in antioxidant functions. J. Sci. Food Agric., 81: 559-568.
12. Blackburn, P., B. Lamarche, C. Couillard, A. Pascot and N. Bergeron, 2003. Postprandial hyperlipidemia: Another correlate of the hypertriglyceridemic waist phenotype in men. Atherosclerosis, 171: 327-336.
13. Britton, G., 1995. Structure and properties of carotenoids in relation to function. FASEB. J., 9: 1551-1558.
14. Buege, J.A. and S.D. Aust, 1978. Microsomal lipid peroxidation. Methods Enz., 52: 302-315.
15. Chakraborti S., T. Chakraborti, M. Mandal, A. Mandal, S. Das and S. Ghosh, 2002. Protective role of magnesium in cardiovascular diseases: A review. Mol. Cell Biochem., 238: 163-179.
16. Chaudari, N. and S.D. Roper, 1998. Molecular and physiological evidence for glutamate (umami) taste transduction via a G-protein-coupled receptor. Ann. N.Y. Acad. Sci., 855: 398-405.
17. +-ATPase activity and ouabain binding sites in hypercholesterolemic rabbits. Basic. Res. Cardiol., 92: 1-7.
18. Chen, C.C. and S.Y. Lin-Shiau, 1988. ATPase activities in the kidney and heart of alloxan induced diabetic mice. Asia Pacific. J. Pharmacol., 3: 51-55.
19. Chen, K., S.R. Thomas and J.F. Keaney, 2003. Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic. Biol. Med., 35: 117-132.
20. Chew, B.P. and J.S. Park, 2004. Carotenoid action on the immune response. J. Nutr., 134: 257S-261S.
21. Choi, D.W., 1994. Calcium and excitotoxic neuronal injury. Ann. N.Y. Acad. Sci., 747: 162-171.
22. Choudhary, P., V.B.T. Malik, S. Puri and P. Ahluwalia, 1996. Studies on the effects of monosodium glutamate on hepatic microsomal lipid peroxidation, calcium, ascorbic acid and glutathione and its dependent enzymes in adult, male mice. Toxicol. Lett., 89: 71-76.
23. Das, U.N., 2000. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol. Cell Biochem., 215: 145-152.
24. Dene, B.A., A.C. Maritim, R.A. Sanders and J.B. Watkins, 2005. Effects of antioxidant treatment on normal and diabetic rat enzyme activities. J. Ocul. Pharmacol., 21: 28-35.
25. Diniz, Y.S., L.A. Faine, J.A. Almeida, M.D.P. Silva, B.O. Ribas and E.L.B. Novelli, 2002. Toxicity of dietary restriction of fat enriched diets on cardiac tissue. Food Chem. Toxicol., 40: 1892-1899.
26. Diniz, Y.S., L.A. Fame, C.M. Galhardi, H.G. Rodrigues and G.X. Ebaid et al., 2005. Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats. Nutration, 21: 749-755.
27. Edes, T.E., W. Thornton and J. Shah, 1989. Beta-carotene and aryl hydrocarbon hydroxylase in the rat: An effect of beta-carotene independent of vitamin A activity. J. Nutr., 119: 796-799.
28. Faine, L.A., Y.S. Diniz, J.A. Almeida and E.L.B. Novelli, 2002. Toxicity of adlibitum overfeeding: Effects on cardiac tissue. Food Chem. Toxicol., 3: 130-137.
29. Farmobi, E.O. and O.O. Onyema, 2006. Monosodium glutamate-induced oxidative damage and genotoxicity in the rat: Modulatory role of vitamin C, vitamin E and quercetin. Hum. Exp. Toxicol., 25: 251-259.
30. Fiske, C.H. and Y. Subbarow, 1925. The colorimetric determination of phosphorus. J. Biol. Chem., 66: 375-400.
31. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18: 499-502.
32. Frings, C.S. and R. Dunn, 1970. A colorimetric method for determination of total lipids based on sulfophosphate-vanillin reaction. Am. J. Clin. Pathol., 4: 53-89.
33. Furusho, T., E. Kataoka, T. Yasuhara, M. Wada and S. Innami, 2002. Administration of beta-carotene suppresses lipid peroxidation in tissues and improves the glucose tolerance ability of streptozotocin-induced diabetic rats. Int. J. Vitam. Nutr. Res., 72: 71-76.
34. Ganesan, B., S. Buddhan, R. Anandan, R. Sivakumar and R. Anbinezhilan, 2009. Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. Mol. Biol. Rep. (In Press). 10.1007/s11033-009-9508-4
35. Gillies, P.J., K.A. Rathgeb, M.A. Perri and C.S. Robinson, 1986. Regulation of acyl-oA: Cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: Role of a cholesterol substrate pool. Exp. Mol. Pathol., 44: 329-339.
36. Ginsberg, H.N., 2002. New perspectives on atherogenesis: Role of abnormal triglyceride-rich lipoprotein metabolism. Circulation, 106: 2137-2142.
37. +)-ATPase activity in hypercholesterolemic rabbit. Int. J. Vit. Nutr. Res., 60: 398-401.
38. Harvey, B.H., C. Joubert, J.L. Preez and M. Berk, 2008. Effect of chronic NAcetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum. Neurochem Res., 33: 508-517.
39. Helzer, Z., Z. Jozwiak and W. Leyko, 1980. Osmotic fragility and lipid peroxidation of irradiated erythrocytes in the presence of radioprotectors. Experientia, 36: 521-522.
40. Hu, M.Y., Y.L Li, C.H. Jiang, Z.Q. Liu, S.L. Qu and Y.M. Huang, 2008. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits. Nutrition, 24: 1030-1038.
41. Jagota, S.K. and H.M. Dani, 1982. A new colorimetric technique for the estimation of vitamin C using folin phenol reagent. Anal. Biochem., 127: 178-182.
42. Kaneto, H., Y. Kajimoto, J. Miyagawa, T. Matsuoka and Y. Fujitani et al., 1999. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic â-cells against glucose toxicity. Diabetes, 48: 2398-2406.
43. Kheir-Eldin, A.A., T.K. Motawi, M.Z. Gad and H.M. Abd-ElGawad, 2001. Protective effect of vitamin E ,â-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. Int. J. Biochem. Cell. Biol., 33: 475-482.
44. Kinne-Saffian, E., M. Hulseweh, C.H. Pfaff and P.K.H. Kinne, 1993. Inhibition of Na-K ATPase by cadmium: different mechanisms indifferent species. Toxicol. Applied Pharmacol., 121: 22-29.
45. Kopp, J., H. Seyhan, B. Muller, J. Lanczak and E. Pausch et al., 2006. N-acetyl-Lcysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling. J. Cell Mol. Med., 10: 157-165.
46. Kutryk, M.J.B. and G.N. Pierce, 1988. Stimulation of sodium-calcium exchange by cholesterol incorporation into isolated cardiac sarcolemmal vesicles. J. Biol. Chem., 263: 13167-13172.
47. Lall, S.B., B. Singh, K. Gulati and S.D. Seth, 1999. Role of nutrition in toxic injury. Ind. J. Exp. Biol., 37: 109-116.
48. Lin, C., M. Yinb, C. Hsub and M. Linb, 2004. Effect of five cysteine-containing compounds on three lipogenic enzymes in balb/cA mice consuming a high saturated fat diet Lipids, 39: 1-6.
49. Lounsbury, K.M., Q. Hu and R.C. Ziegelstein, 2000. Calcium signaling and oxidant stress in the vasculature. Free Rad. Biol. Med., 28: 1362-1369.
50. Lundman, P., M.J. Eriksson, M. Stuhlinger, J.P. Cooke, A. Hamsten and P. Tornvall, 2001. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J. Am. Coll. Cardiol., 38: 111-116.
51. Lupattelli, G., R. Lombardini, G. Schillaci, G. Ciuffetti, S. Marchesi, D. Siepi and E. Mannarino, 2000. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: Association with small, dense LDL cholesterol particles. Am. Heart J., 140: 521-526.
52. Maiani, G., M.J.P. Caston, G. Catasta, E. Toti and I.G. Cambrodon et al., 2008. Carotenoids: Actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol. Nutr. Food Res., (In Press).
53. Mallick, H.N., 2007. Understanding safety of glutamate in food and brain. Ind. J. Physiol. Pharmacol., 51: 216-234.
54. Mallika, V., B. Goswami and M. Rajappa, 2007. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology, 58: 513-522.
55. Mangels, AR., J.M. Holden, G.R. Beecher, M.R. Forman and E. Lanza, 1993. Carotenoid content of fruits and vegetables: An evaluation of analytic data. J. Am. Diet Assoc., 93: 284-296.
56. Maxfield, F.R. and I. Tabas, 2005. Role of cholesterol and lipid organization in disease. Nature, 438: 612-621.
57. McEligot, A.J., S. Yang and F.L. Jr. Meyskens, 2005. Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Annu. Rev. Nutr., 25: 261-295.
58. Miwa, I., J. Okuda, K. Maeda and G. Okuda, 1972. Mutarotase effect on colorimetric determination of blood glucose with D-glucose oxidase. Clin. Chem. Acta., 37: 538-540.
59. Moncada, S., R.M. Palmer and E.A. Higgs, 1991. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43: 109-142.
60. Moshage, H., B. Kok, J.R. Huizenga and P.L. Jansen, 1995. Nitrite and nitrate determination in plasma: A critical evaluation. Clin. Chem., 41: 892-896.
61. Murata, Y., M. Amao and J. Hamuro, 2003. Sequential conversion of the redox status of macrophages dictates the pathological progression of autoimmune diabetes. Eur. J. Immunol., 33: 1001-1011.
62. Naderali, E.K., S. Fatani and G. Williams, 2004. Chronic withdrawal of a highpalatable obesity-induced diet completely reverses metabolic and vascular abnormalities associated with dietary-obesity in the rat. Atherosclerosis, 172: 63-69.
63. Nagata, M., W. Suzuki, S. Iizuka, M. Tabuchi and H. Maruyama et al., 2006. Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate. Exp. Anim., 55: 109-115.
64. Ness, G.C. and C.M. Chambers, 2000. Feedback and hormonal regulation of hepatic 3-Hydroxy-3-methylglutaryl coenzyme a reductase: The concept of cholesterol buffering capacity. Soci. Exp. Biol. Med., 224: 8-19.
65. Norgaard, A., U. Baandrup, J.S. Larsen and K. Kjeldsen, 1987. Heart Na,K-ATPase activity in cardiomyopathic hamsters as estimated from K-dependent 3-0- MFPase activity in crude homogenate. J. Mol. Cell Cardiol., 19: 589-594.
66. Ortega, A. and J. Mas-Oliva, 1984. Cholesterol effect on enzyme activity of the sarcolemmal Biochim. Biophys. Acta., 773: 231-236.
67. Paez, F.G. and A.B.Z. Omez, 2009. Endothelial dysfunction and cardiovascular risk factors. Diabetes Res. Clin. Practice, 84: 1-10.
68. Pahan, K., F.G. Sheikh, M. Khan, A.M.S. Namboodiri and I. Singh, 1998. Sphingomyelinase and ceramide stimulate the expression of inducible nitric oxide synthase in rat primary astrocytes. J. Biol. Chem., 273: 2591-2600.
69. Pal, M., 2009. HDL Therapeutics for the treatment of atherosclerosis: A brief overview of the synthetic approaches. Tetrahedron, 65: 433-447.
70. Paoletti, F., D. Aldinucci, A. Mocali and A. Caparrini, 1986. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal. Biochem., 154: 536-541.
71. Pocernich, C.B. and M. La Fontaine, 2000. In vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in at brain. Neurochem. Int., 36: 185-191.
72. Prakash, A. and A. Kumar, 2009. Effect of N-acetyl cysteine against aluminium-induced cognitive dysfunction and oxidative damage in rats. Basic Clin. Pharmacol. Toxicol., 453: 86-91.
73. Ritter, C., A. Reinke, M. Andrades, M.R. Martins and J. Rocha et al., 2004. Protective effect of N-acetyl cysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit. Care Med., 32: 2079-2084.
74. Roberts, C.K. and K.K. Sindhu, 2009. Oxidative stress and metabolic syndrome. Life Sci., 84: 705-712.
75. Rosalki, S.B., 1967. An improved procedure for serum creatine phosphokinase determination. J. Lab. Clin. Med., 69: 696-705.
76. Russell, R.M., 2004. The enigma of beta-carotene in carcinogenesis: What can be learned from animal studies? J. Nutr., 134: 262S-268S.
77. Sayed-Ahmed, M.M., M.M. Khattab, M.Z. Gad and A.M. Osman, 2001. Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathay. Pharmacol. Toxicol., 89: 140-144.
78. Schünemann, H.J., S. McCann, B.J. Grant, M. Trevisan, P. Muti and J.L. Freudenheim, 2002. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-basedstudy. Am. J. Epidemiol., 155: 463-471.
79. Seraphim, P.M., M.T. Nunes and U.F. Machado, 2001. GLUT 4 protein expression in obese and lean 12-month-old rats. Braz. J. Med. Biol. Res., 34: 1353-1362.
80. Sharma, J.N., A. Al-Omran and S.S. Parvathy, 2007. Role of nitric oxide in inflammatory diseases. Inflammopharmacol, 15: 252-259.
81. Singh, P., K.A. Mann, H.K. Mangat and G. Kaur, 2003. Prolonged glutamate excitotoxicity: Effects of mitochondrial antioxidants and antioxidant enzymes. Mol. Cell Biochem., 243: 139-145.
82. Singh, K. and A. Pushpa, 2005. Alteration in some antioxidant enzymes in cardiac tissue upon monosodium glutamate (MSG) administration to adult male mice. Indian J. Clin. Biochem., 20: 43-46.
83. Stahl, W., 2000. Lipid oxidation and antioxidants. Curr. Opin. Clin. Nutr. Metab. Care., 3: 121-126.
84. Stauss, H.M., B. Nafz, R. Mrowka and P.B. Persson, 2000. Blood pressure control in eNOS knock out mice: Comparison with other species under NO blockade. Acta. Physiol. Scand., 168: 155-160.
85. Stein, E.A., 1986. Textbook of Clinical Chemistry. WB Saunders and NW Tietz, Philadelphia, pp: 879.
86. Stokes, K.Y., D. Cooper, A. Taillor and D.N. Granger, 2002. Hypercholesterolemia promotes inflammation and microvascular dysfunction : Role of nitric oxide and superoxide. Free Radical Biol. Med., 33: 1026-1036.
87. Suchalata, S. and C.S.D. Shyamala, 2004. Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol. Int. J. Exp. Biol., 42: 174-178.
88. Takano, H., Y. Zou, H. Hasegawa, H. Akazawa, T. Nagi and I. Komuro, 2003. Oxidative stressinduced signal transduction pathways in cardiacmyocytes: involvement of ROS in heart diseases. Antioxid. Redox. Signal, 6: 789-794.
89. Tavani, A. and C. La Vechia, 1999. Beta-carotene and risk of coronary heart disease. A review of observational and intervention studies. Biomed. Pharmacother, 53: 409-416.
90. Tepel, M., G.M. van der, M. Statz, J. Jankowski and W. Zidek, 2003. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure. Circulation, 107: 992-995.
91. Tsakiris, S. and G. Dliconstantinos, 1984. Influence of phosphatidylserine on Na+/K+ stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem. J., 22: 301-307.
92. Vivekananthan, D.P., M.S. Penn, S.K. Sapp, A. Hsu and E.J. Topol, 2003. Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials. Lancet, 361: 2017-2023.
93. Vladimirov, Y.A., V.I. Olenev, T.B. Suslova and Z.P. Cheremisina, 1980. Lipid Peroxidation in Mitochondrial Membrane. In: Advances in Lipid Research, Paoletti, R. and D. Kritchevsky (Eds.). Vol. 17, Academic Press, New York, pp: 173-249.
94. Voghel, G., N. Thorin-Trescases, N. Farhat, A.M. Mamarbachi and L. Villeneuve et al., 2008. Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech. Ageing. Dev., 129: 261-270.
95. Wahlefeld, A.W., 1974. Method of Enzymatic Analysis. Vol. 5, Academic Press, New York, pp: 1831-1835.
96. Walker, R. and J.R. Lupien, 2000. The safety evaluation of monosodium glutamate. J. Nutr., 130: 1049S-1052S.
97. Wang, H.X. and T.B. Ng, 1999. Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiarherosclerotic and antithrombotic activities. Life Sci., 65: 2663-2677.
98. Wang, X.D. and R.M. Russell, 1999. Procarcinogenic and anticarcinogenic effects of beta-carotene. Nutr. Rev., 57: 263-272.
99. Yalçin, S., A. Bilgili, I. Onbasilar, G. Eraslan and M. Ozdemir, 2008. Synergistic action of sodium selenite and N-acetylcysteine in acetaminophen induced liver damage. Hum. Exp. Toxicol., 27: 425-429.
100. Yamashita, H., S. Ehara, M. Yoshiyama, T. Naruko and K. Haze et al., 2007. Elevated plasma levels of oxidized low-density lipoprotein relate to the presence of angiographically detected complex and thrombotic coronary artery lesion morphology in patients with unstable angina. Circ. J., 71: 681-687.
101. Yang, R., G. Le, A. Li, J. Zheng and Y. Shi, 2006. Effect of antioxidant capacity on blood lipid metabolism and lipoprotein lipase activity of rats fed a high-fat diet. Nutration, 22: 1185-1191.
102. Yeagle, P.L., 1989. Lipid regulation of cell membrane structure and function. FASEB. J., 3: 1833-1842.
103. Yeh, S.L., H.M. Wang, P.Y. Chen and T.C. Wu, 2009. Interactions of β-carotene and flavonoids on the secretion of pro-inflammatory mediators in an in vitro system. Chemico-Biological Interactions, 179: 386-393.
104. Zafarullah, M., W.Q. Li, J. Sylvester and M. Ahmad, 2003. Molecular mechanisms of N-acetylcystein actions. Cell Mol. Life Sci., 60: 6-20.
105. Zar, J., 1999. Biostatistical Analysis. 4th Edn., Prentice Hall, Upper Saddle River, New Jersey.
106. Zavaroni, I., E. Bonora, M. Pagliara, E. Dall'Aglio and L. Luchetti et al., 1989. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N. Engl. J. Med., 320: 702-706.